Gene: PLEKHA5
Official Full Name: pleckstrin homology domain containing A5provided by HGNC
Gene Summary: Predicted to enable phosphatidylinositol phosphate binding activity. Predicted to act upstream of or within reproductive system development. Located in cytosol and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO21714 | PLEKHA5 Knockout cell line (HeLa) | Human | PLEKHA5 | 1:3~1:6 | Negative | Online Inquiry |
KO21715 | PLEKHA5 Knockout cell line (HCT 116) | Human | PLEKHA5 | 1:2~1:4 | Negative | Online Inquiry |
KO21716 | PLEKHA5 Knockout cell line (HEK293) | Human | PLEKHA5 | 1:3~1:6 | Negative | Online Inquiry |
KO21717 | PLEKHA5 Knockout cell line (A549) | Human | PLEKHA5 | 1:3~1:4 | Negative | Online Inquiry |
PLEKHA5 Gene Knockout Cell Lines are genetically modified cell lines that have been engineered to produce a complete knockout of the PLEKHA5 gene, which encodes a critical scaffolding protein associated with cellular signaling pathways. These cell lines serve as invaluable tools for researchers aiming to elucidate the function of PLEKHA5 in various biological processes, including cell adhesion, migration, and signal transduction. By effectively silencing this gene, these cell lines facilitate the study of its role in disease pathogenesis, particularly in cancer and neurodegenerative disorders.
The primary mechanism by which PLEKHA5 knockout cell lines operate involves the disruption of PLEKHA5 mRNA using CRISPR-Cas9 technology. This precise genome-editing tool allows for specific alterations to the cell's DNA, leading to a functional deficiency of the protein product. With the absence of PLEKHA5, researchers can closely investigate the downstream effects on cellular behavior and signaling, thus providing insights into the gene's function and potential therapeutic targets.
The scientific significance of PLEKHA5 knockout cell lines lies in their broad applicability in both basic research and preclinical studies. They can be used to model various physiological conditions and diseases, offering researchers the opportunity to assess drug responses or the underlying molecular mechanisms of pathologies. Their utility in drug discovery accelerates the identification of novel therapeutic agents that target specific pathways influenced by PLEKHA5.
Compared to alternative methods for gene silencing, such as siRNA or shRNA approaches, these knockout cell lines provide a stable and heritable modification that ensures the consistency of experimental results. Researchers benefit from the time-saving designs since the knockout is established before use, and thus eliminates variability associated with transfection methods. Additionally, using this advanced genetic manipulation enhances reproducibility in experiments.
For researchers and clinicians seeking robust models for studying gene function and its implications in health and disease, PLEKHA5 Gene Knockout Cell Lines represent an essential asset in their toolkit. Their unique capabilities and reliability make them premier choices for advancing scientific knowledge and developing new treatment strategies.
Our company prides itself on its commitment to excellence in genetic engineering technologies, providing high-quality biological products that empower researchers and clinicians alike in their quest to push the boundaries of scientific discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.